Global Latent Tuberculosis Infection (LTBI) Testing Market Research Report 2024(Status and Outlook)
Report Overview:
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The Global Latent Tuberculosis Infection (LTBI) Testing Market Size was estimated at USD 1480.91 million in 2023 and is projected to reach USD 2030.35 million by 2029, exhibiting a CAGR of 5.40% during the forecast period.
This report provides a deep insight into the global Latent Tuberculosis Infection (LTBI) Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Latent Tuberculosis Infection (LTBI) Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Latent Tuberculosis Infection (LTBI) Testing market in any manner.
Global Latent Tuberculosis Infection (LTBI) Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Market Segmentation (by Type)
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Market Segmentation (by Application)
Hospitals and Clinics
Diagnostic Laboratories
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Latent Tuberculosis Infection (LTBI) Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The Global Latent Tuberculosis Infection (LTBI) Testing Market Size was estimated at USD 1480.91 million in 2023 and is projected to reach USD 2030.35 million by 2029, exhibiting a CAGR of 5.40% during the forecast period.
This report provides a deep insight into the global Latent Tuberculosis Infection (LTBI) Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Latent Tuberculosis Infection (LTBI) Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Latent Tuberculosis Infection (LTBI) Testing market in any manner.
Global Latent Tuberculosis Infection (LTBI) Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Market Segmentation (by Type)
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Market Segmentation (by Application)
Hospitals and Clinics
Diagnostic Laboratories
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Latent Tuberculosis Infection (LTBI) Testing Market
- Overview of the regional outlook of the Latent Tuberculosis Infection (LTBI) Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Latent Tuberculosis Infection (LTBI) Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Latent Tuberculosis Infection (LTBI) Testing
1.2 Key Market Segments
1.2.1 Latent Tuberculosis Infection (LTBI) Testing Segment by Type
1.2.2 Latent Tuberculosis Infection (LTBI) Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Manufacturers (2019-2024)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Latent Tuberculosis Infection (LTBI) Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Latent Tuberculosis Infection (LTBI) Testing Sales Sites, Area Served, Product Type
3.6 Latent Tuberculosis Infection (LTBI) Testing Market Competitive Situation and Trends
3.6.1 Latent Tuberculosis Infection (LTBI) Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Latent Tuberculosis Infection (LTBI) Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING INDUSTRY CHAIN ANALYSIS
4.1 Latent Tuberculosis Infection (LTBI) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2019-2024)
6.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2019-2024)
6.4 Global Latent Tuberculosis Infection (LTBI) Testing Price by Type (2019-2024)
7 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Sales by Application (2019-2024)
7.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Latent Tuberculosis Infection (LTBI) Testing Sales Growth Rate by Application (2019-2024)
8 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET SEGMENTATION BY REGION
8.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Latent Tuberculosis Infection (LTBI) Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Latent Tuberculosis Infection (LTBI) Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Latent Tuberculosis Infection (LTBI) Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Qiagen
9.1.1 Qiagen Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.1.2 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.1.4 Qiagen Business Overview
9.1.5 Qiagen Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
9.1.6 Qiagen Recent Developments
9.2 Sanofi
9.2.1 Sanofi Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.2.2 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.2.4 Sanofi Business Overview
9.2.5 Sanofi Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
9.2.6 Sanofi Recent Developments
9.3 Oxford Immunotec
9.3.1 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.3.2 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.3.4 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
9.3.5 Oxford Immunotec Business Overview
9.3.6 Oxford Immunotec Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.4.2 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 Par Sterile
9.5.1 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.5.2 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.5.4 Par Sterile Business Overview
9.5.5 Par Sterile Recent Developments
9.6 Bio-Rad Laboratories
9.6.1 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.6.2 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.6.4 Bio-Rad Laboratories Business Overview
9.6.5 Bio-Rad Laboratories Recent Developments
10 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET FORECAST BY REGION
10.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast
10.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country
10.2.3 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Region
10.2.4 South America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Latent Tuberculosis Infection (LTBI) Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Latent Tuberculosis Infection (LTBI) Testing by Type (2025-2030)
11.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Latent Tuberculosis Infection (LTBI) Testing by Type (2025-2030)
11.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2025-2030)
11.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) Forecast by Application
11.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Latent Tuberculosis Infection (LTBI) Testing
1.2 Key Market Segments
1.2.1 Latent Tuberculosis Infection (LTBI) Testing Segment by Type
1.2.2 Latent Tuberculosis Infection (LTBI) Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Manufacturers (2019-2024)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Latent Tuberculosis Infection (LTBI) Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Latent Tuberculosis Infection (LTBI) Testing Sales Sites, Area Served, Product Type
3.6 Latent Tuberculosis Infection (LTBI) Testing Market Competitive Situation and Trends
3.6.1 Latent Tuberculosis Infection (LTBI) Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Latent Tuberculosis Infection (LTBI) Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING INDUSTRY CHAIN ANALYSIS
4.1 Latent Tuberculosis Infection (LTBI) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2019-2024)
6.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2019-2024)
6.4 Global Latent Tuberculosis Infection (LTBI) Testing Price by Type (2019-2024)
7 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Sales by Application (2019-2024)
7.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Latent Tuberculosis Infection (LTBI) Testing Sales Growth Rate by Application (2019-2024)
8 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET SEGMENTATION BY REGION
8.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Latent Tuberculosis Infection (LTBI) Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Latent Tuberculosis Infection (LTBI) Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Latent Tuberculosis Infection (LTBI) Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Qiagen
9.1.1 Qiagen Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.1.2 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.1.4 Qiagen Business Overview
9.1.5 Qiagen Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
9.1.6 Qiagen Recent Developments
9.2 Sanofi
9.2.1 Sanofi Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.2.2 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.2.4 Sanofi Business Overview
9.2.5 Sanofi Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
9.2.6 Sanofi Recent Developments
9.3 Oxford Immunotec
9.3.1 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.3.2 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.3.4 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
9.3.5 Oxford Immunotec Business Overview
9.3.6 Oxford Immunotec Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.4.2 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 Par Sterile
9.5.1 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.5.2 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.5.4 Par Sterile Business Overview
9.5.5 Par Sterile Recent Developments
9.6 Bio-Rad Laboratories
9.6.1 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.6.2 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.6.4 Bio-Rad Laboratories Business Overview
9.6.5 Bio-Rad Laboratories Recent Developments
10 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET FORECAST BY REGION
10.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast
10.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country
10.2.3 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Region
10.2.4 South America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Latent Tuberculosis Infection (LTBI) Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Latent Tuberculosis Infection (LTBI) Testing by Type (2025-2030)
11.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Latent Tuberculosis Infection (LTBI) Testing by Type (2025-2030)
11.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2025-2030)
11.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) Forecast by Application
11.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Latent Tuberculosis Infection (LTBI) Testing Market Size Comparison by Region (M USD)
Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2022)
Table 10. Global Market Latent Tuberculosis Infection (LTBI) Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Latent Tuberculosis Infection (LTBI) Testing Sales Sites and Area Served
Table 12. Manufacturers Latent Tuberculosis Infection (LTBI) Testing Product Type
Table 13. Global Latent Tuberculosis Infection (LTBI) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Latent Tuberculosis Infection (LTBI) Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Latent Tuberculosis Infection (LTBI) Testing Market Challenges
Table 22. Global Latent Tuberculosis Infection (LTBI) Testing Sales by Type (K Units)
Table 23. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (M USD)
Table 24. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2019-2024)
Table 26. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Type (2019-2024)
Table 28. Global Latent Tuberculosis Infection (LTBI) Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) by Application
Table 30. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
Table 31. Global Latent Tuberculosis Infection (LTBI) Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application (2019-2024)
Table 33. Global Latent Tuberculosis Infection (LTBI) Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2019-2024)
Table 35. Global Latent Tuberculosis Infection (LTBI) Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Latent Tuberculosis Infection (LTBI) Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region (2019-2024)
Table 38. North America Latent Tuberculosis Infection (LTBI) Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Latent Tuberculosis Infection (LTBI) Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Latent Tuberculosis Infection (LTBI) Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales by Region (2019-2024) & (K Units)
Table 43. Qiagen Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 44. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 45. Qiagen Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Qiagen Business Overview
Table 47. Qiagen Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
Table 48. Qiagen Recent Developments
Table 49. Sanofi Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 50. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 51. Sanofi Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Sanofi Business Overview
Table 53. Sanofi Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
Table 54. Sanofi Recent Developments
Table 55. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 56. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 57. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
Table 59. Oxford Immunotec Business Overview
Table 60. Oxford Immunotec Recent Developments
Table 61. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 62. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 63. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Recent Developments
Table 66. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 67. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 68. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Par Sterile Business Overview
Table 70. Par Sterile Recent Developments
Table 71. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 72. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 73. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Bio-Rad Laboratories Business Overview
Table 75. Bio-Rad Laboratories Recent Developments
Table 76. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 77. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 79. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 81. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 83. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 85. South America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 89. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Latent Tuberculosis Infection (LTBI) Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 91. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) Forecast by Application (2025-2030)
Table 92. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Latent Tuberculosis Infection (LTBI) Testing Market Size Comparison by Region (M USD)
Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2022)
Table 10. Global Market Latent Tuberculosis Infection (LTBI) Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Latent Tuberculosis Infection (LTBI) Testing Sales Sites and Area Served
Table 12. Manufacturers Latent Tuberculosis Infection (LTBI) Testing Product Type
Table 13. Global Latent Tuberculosis Infection (LTBI) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Latent Tuberculosis Infection (LTBI) Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Latent Tuberculosis Infection (LTBI) Testing Market Challenges
Table 22. Global Latent Tuberculosis Infection (LTBI) Testing Sales by Type (K Units)
Table 23. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (M USD)
Table 24. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2019-2024)
Table 26. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Type (2019-2024)
Table 28. Global Latent Tuberculosis Infection (LTBI) Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) by Application
Table 30. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
Table 31. Global Latent Tuberculosis Infection (LTBI) Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application (2019-2024)
Table 33. Global Latent Tuberculosis Infection (LTBI) Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2019-2024)
Table 35. Global Latent Tuberculosis Infection (LTBI) Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Latent Tuberculosis Infection (LTBI) Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region (2019-2024)
Table 38. North America Latent Tuberculosis Infection (LTBI) Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Latent Tuberculosis Infection (LTBI) Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Latent Tuberculosis Infection (LTBI) Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales by Region (2019-2024) & (K Units)
Table 43. Qiagen Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 44. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 45. Qiagen Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Qiagen Business Overview
Table 47. Qiagen Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
Table 48. Qiagen Recent Developments
Table 49. Sanofi Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 50. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 51. Sanofi Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Sanofi Business Overview
Table 53. Sanofi Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
Table 54. Sanofi Recent Developments
Table 55. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 56. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 57. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
Table 59. Oxford Immunotec Business Overview
Table 60. Oxford Immunotec Recent Developments
Table 61. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 62. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 63. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Recent Developments
Table 66. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 67. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 68. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Par Sterile Business Overview
Table 70. Par Sterile Recent Developments
Table 71. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Basic Information
Table 72. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 73. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Bio-Rad Laboratories Business Overview
Table 75. Bio-Rad Laboratories Recent Developments
Table 76. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 77. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 79. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 81. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 83. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 85. South America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 89. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Latent Tuberculosis Infection (LTBI) Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 91. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) Forecast by Application (2025-2030)
Table 92. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Latent Tuberculosis Infection (LTBI) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD), 2019-2030
Figure 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) (2019-2030)
Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (M USD)
Figure 11. Latent Tuberculosis Infection (LTBI) Testing Sales Share by Manufacturers in 2023
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Manufacturers in 2023
Figure 13. Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Latent Tuberculosis Infection (LTBI) Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type
Figure 18. Sales Market Share of Latent Tuberculosis Infection (LTBI) Testing by Type (2019-2024)
Figure 19. Sales Market Share of Latent Tuberculosis Infection (LTBI) Testing by Type in 2023
Figure 20. Market Size Share of Latent Tuberculosis Infection (LTBI) Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Latent Tuberculosis Infection (LTBI) Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application
Figure 24. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application in 2023
Figure 26. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2019-2024)
Figure 27. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application in 2023
Figure 28. Global Latent Tuberculosis Infection (LTBI) Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Country in 2023
Figure 32. U.S. Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Latent Tuberculosis Infection (LTBI) Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Country in 2023
Figure 37. Germany Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region in 2023
Figure 44. China Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (K Units)
Figure 50. South America Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Country in 2023
Figure 51. Brazil Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Latent Tuberculosis Infection (LTBI) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD), 2019-2030
Figure 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) (2019-2030)
Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (M USD)
Figure 11. Latent Tuberculosis Infection (LTBI) Testing Sales Share by Manufacturers in 2023
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Manufacturers in 2023
Figure 13. Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Latent Tuberculosis Infection (LTBI) Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type
Figure 18. Sales Market Share of Latent Tuberculosis Infection (LTBI) Testing by Type (2019-2024)
Figure 19. Sales Market Share of Latent Tuberculosis Infection (LTBI) Testing by Type in 2023
Figure 20. Market Size Share of Latent Tuberculosis Infection (LTBI) Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Latent Tuberculosis Infection (LTBI) Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application
Figure 24. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application in 2023
Figure 26. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2019-2024)
Figure 27. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application in 2023
Figure 28. Global Latent Tuberculosis Infection (LTBI) Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Country in 2023
Figure 32. U.S. Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Latent Tuberculosis Infection (LTBI) Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Country in 2023
Figure 37. Germany Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region in 2023
Figure 44. China Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (K Units)
Figure 50. South America Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Country in 2023
Figure 51. Brazil Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2025-2030)
